Your browser is no longer supported. Please, upgrade your browser.
Forte Biosciences, Inc.
Index- P/E- EPS (ttm)-1.61 Insider Own9.20% Shs Outstand13.60M Perf Week1.11%
Market Cap41.05M Forward P/E- EPS next Y-0.75 Insider Trans-42.65% Shs Float12.64M Perf Month-16.97%
Income-20.30M PEG- EPS next Q-0.36 Inst Own53.20% Short Float11.52% Perf Quarter-91.18%
Sales- P/S- EPS this Y84.30% Inst Trans-14.05% Short Ratio0.66 Perf Half Y-92.70%
Book/sh3.67 P/B0.75 EPS next Y48.60% ROA-41.90% Target Price3.25 Perf Year-91.76%
Cash/sh- P/C- EPS next 5Y- ROE-44.10% 52W Range2.61 - 43.57 Perf YTD-92.47%
Dividend- P/FCF- EPS past 5Y19.50% ROI- 52W High-93.71% Beta0.71
Dividend %- Quick Ratio17.40 Sales past 5Y- Gross Margin- 52W Low4.98% ATR0.19
Employees10 Current Ratio17.40 Sales Q/Q- Oper. Margin- RSI (14)22.54 Volatility6.64% 6.08%
OptionableYes Debt/Eq0.00 EPS Q/Q95.50% Profit Margin- Rel Volume0.33 Prev Close2.72
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.22M Price2.74
Recom3.20 SMA20-3.32% SMA50-72.70% SMA200-90.14% Volume743,761 Change0.74%
Sep-20-21Upgrade Chardan Capital Markets Sell → Buy $4 → $3.50
Sep-03-21Downgrade Truist Buy → Hold $4
Sep-03-21Downgrade Ladenburg Thalmann Buy → Neutral
Sep-03-21Downgrade Chardan Capital Markets Buy → Sell $105 → $4
Sep-03-21Downgrade B. Riley Securities Buy → Neutral $3
May-14-21Initiated B. Riley Securities Buy $73
Mar-26-21Initiated Citigroup Buy $75
Aug-28-20Upgrade Chardan Capital Markets Neutral → Buy $45
Aug-25-20Initiated Truist Buy $70
Sep-09-21 06:15PM  
Sep-08-21 08:51AM  
Sep-07-21 09:40PM  
Sep-06-21 12:42PM  
Sep-03-21 07:42PM  
Sep-02-21 04:05PM  
Aug-16-21 04:05PM  
Aug-02-21 04:01PM  
Jul-12-21 04:01PM  
Jul-07-21 10:02AM  
Jul-01-21 04:01PM  
May-14-21 03:06AM  
May-10-21 04:05PM  
May-03-21 04:30PM  
Mar-25-21 08:42AM  
Mar-24-21 08:00AM  
Mar-17-21 04:05PM  
Feb-23-21 04:01PM  
Feb-18-21 04:01PM  
Feb-13-21 03:18AM  
Feb-12-21 04:01PM  
Dec-02-20 11:26PM  
Nov-24-20 04:05PM  
Nov-16-20 04:05PM  
Nov-15-20 09:00AM  
Nov-10-20 04:05PM  
Nov-09-20 04:05PM  
Nov-02-20 04:30PM  
Oct-29-20 08:00AM  
Oct-28-20 04:09PM  
Oct-26-20 08:30AM  
Sep-29-20 09:00AM  
Sep-16-20 08:48AM  
Sep-09-20 04:01PM  
Aug-25-20 08:30AM  
Aug-10-20 04:00PM  
Aug-03-20 09:00AM  
Jul-28-20 08:30AM  
Jun-18-20 08:30AM  
Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company was incorporated in 2007 and is based in Torrance, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Riley Antony AChief Financial OfficerSep 07Sale4.2425,000106,10511,065Sep 07 04:09 PM
Wagner Paul A.See RemarksSep 07Sale4.351,000,0004,347,1001,279,049Sep 08 05:02 PM
DARCY THOMAS EDirectorJan 13Option Exercise9.595004,7932,358Jan 14 07:17 PM